Effectiveness of Percutaneous Needle Aponeurotomy

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jan 7, 2019

Keywords

ClinConnect Summary

This clinical trial is studying a treatment for Dupuytren's disease, a condition that causes one or more fingers to bend towards the palm due to thickening tissue in the hand. The researchers want to find out if a procedure called percutaneous needle aponeurotomy is as effective and safe as traditional open surgery for treating this condition. By exploring this new approach, they hope to offer a treatment option that could reduce the need for surgery.

To participate in this trial, you must be at least 18 years old and have Dupuytren's disease with a noticeable bending of at least one finger. It's important that you do not have other hand problems or have had previous surgeries that affect finger movement. If you join the study, you will receive treatment and be monitored for how well it works and its safety. This trial is open to all eligible individuals, and those interested in participating should be willing to provide informed consent.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years old
• • Ascertained Dupuytren disease: palpable fibrotic nodule or cord developed from the palmar aponeurosis, flexion contracture of a metacarpophalangeal or proximal interphalangeal joint.
• • Presence of at least one flexion contracture of a metacarpophalangeal joint of the hand due to Dupuytren's disease and \> or = 20°
• • Written informed consent signed by the patient
• • Patient affiliated to the social security
• Exclusion Criteria:
• • Presence of other musculoskeletal disorders of the hand than Dupuytren's disease: known inflammatory rheumatic disease of the hand, clinical signs of inflammatory rheumatic disease of the hand, MP or PIP pain at inclusion visit.
• • Previous surgery of the hand to be treated resulting in functional limitation or limitation of finger mobility
• • Any other pathological condition or limited range of motion in the finger to be treated
• • Psychiatric status precluding patient evaluation; vulnerable persons; adults under legal protection order or incompetent, physically or mentally incapable of giving his consent.
• • Pregnant or beastfeeding women
• • Participation in another interventional trial